Bioequivalence evaluation of three different oral formulations of ciprofloxacin in healthy volunteers

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 28, Issue 2, 2003, Pages 129-136

  Maya, Manuela T ^a   Gonçalves, Nuno J ^b   Silva, Nuno E ^b   Filipe, Augusto E ^c   Morais, José A ^b  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b UNIVERSITY OF LISBON   (Portugal)

^c NONE

Author keywords

Bioavailability; Bioequivalence; Ciprofloxacin; Human pharmacokinetics

Indexed keywords

CIPROFLOXACIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG FORMULATION; DRUG RELEASE; DRUG TRANSFORMATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OPEN STUDY; RANDOMIZED CONTROLLED TRIAL; TABLET; ULTRAVIOLET RADIATION;

EID: 0038780873     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190501     Document Type: Article

References (13)

1. Bauernfeind A., Petermuller C. (1983): In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid. Eur. J. Clin. Microbiol., 2, 111-115.
2. N. Bacracheva et al. (1991): The distribution of ciprofloxacin and its metabolites in human plasma, pulmonary and bronchial tissues. International Journal of Clinic Pharmacology, Therapy and Toxicology, 9, 352-356.
3. Fabre (1991): Steady-State Pharmacokinetics of Ciprofloxacin in Plasma from Patients with Nosocomial Pneumonia: Penetration of the Bronchial Mucosa. Antimicrobial Agents and Chemotherapy, 12, 2521-2525.
4. Beerman D., Scholl H., Wingender W., Forster D., Beubler E., et al. (1986): Metabolism of ciprofloxacinin man. In Neu HC & Weuta H. (Eds) 1st International Workshop, Leverkusen 1985, 141-146, Excerpta Medica, Amsterdam.
5. Borner K., Lode H., Hoffken G., (1986): Renal elimination of sulphociprofloxacin, a new metabolite of ciprofloxacin. European Journal of Clinical Microbiology, 5, 476-480.
6. Dilleti E., Hauschke D. and Steinijans V. W. (1992): Sample size determination for bioequivalence assessment by means of confidence intervals. Int. J. Clin. Pharmacol. Ther. Toxicol., 29, 51-58.
7. Galicia I., Frias Iniesta J., Carcas A.J., Soto A., Gomez E., Miranda E., Fernandez A., Montuenga C. (1998): Bioequivalence evaluation of 2 different oral formulations of ciprofloxacin in healthy volunteers. Int. J. Clin. Pharmacol. Ther., 36 (5), 582-585.
8. Manuela T. Maya, Nuno J. Gonçalves, Nuno E. Silva and José A. Morais (2001): Simple high-performance assay for the determination in human plasma with ultraviolet detection. Journal of Chromatography B, 755, 305-309.
9. Retting Zinke R., WinBioQ: A software package for Statistical Analysis of Bioavailability Studies", version 3.2. Coesfeld.
10. Westlake W.J. (1979): Statistical aspects of comparative bioavailability trials. Biometrics, 35: 273-280.
11. Schuirmann D.J. (1987): A comparison of two one-sided tests procedure and the power approach to assessing the bioequivalence of average bioavailability. J. Pharmacokin. Biopharm., 15, 657-680.
12. Siegal S, Castellan Jr. N.J. (1988) Nonparametric statistics for the Behavioral Sciences 2nd. Ed. ISBN 0-07-057357-30. McGraw Hill Book Company New York p.87-95
13. Note for Guidance on the Investigation of Bioavailability and Bioequivalence: CPMP/EWP/QWP/1401/98.